Antimicrobial agents and Burkholderia pseudomallei: perspectives from Thailand

1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989; 159:890-99.10.1093/infdis/159.5.890Open DOISearch in Google Scholar

2. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis. 1989; 11:413-25.10.1093/clinids/11.3.413Open DOISearch in Google Scholar

3. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005; 18:383-416.10.1128/CMR.18.2.383-416.2005Open DOISearch in Google Scholar

4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124:783-801.10.1016/j.cell.2006.02.015Open DOISearch in Google Scholar

5. Wiersinga WJ, van der Poll T. Immunity to Burkholderia pseudomallei. Curr Opin Infect Dis. 2009; 22:102-8.10.1097/QCO.0b013e328322e727Open DOISearch in Google Scholar

6. Wiersinga W, Wieland C, Dessing M, Chantratita N, Cheng AC. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 2007; 4:e248.10.1371/journal.pmed.0040248Open DOISearch in Google Scholar

7. Panomket P, Splitter G, Harms J, Sermswan RW, Chedchotisakd P, Wongratanacheewin S. TBK1 does not play a role in the control of in vitro Burkholderia pseudomallei growth. Trans R Soc Trop Med Hyg. 2008; 102 (suppl 1):S95-100.10.1016/S0035-9203(08)70023-3Open DOISearch in Google Scholar

8. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun. 1999; 67: 3593-600.10.1128/IAI.67.7.3593-3600.199911654910377144Search in Google Scholar

9. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptor and immune recognition. Ann Rev Immunol. 2005; 23: 901-44.10.1146/annurev.immunol.23.021704.11581615771589Open DOISearch in Google Scholar

10. Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PloS Negl Trop Dis. 2009; 3:e407.10.1371/journal.pntd.0000407266060919352426Open DOISearch in Google Scholar

11. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000; 177: 195-203.10.1034/j.1600-065X.2000.17706.xOpen DOISearch in Google Scholar

12. Segal AW. How neutrophils kill microbes. Ann Rev Immunol. 2004; 23:197-223.10.1146/annurev.immunol.23.021704.115653Open DOISearch in Google Scholar

13. Tippayawat P, Saenwongsa W, Mahawantung J, Suwannasaen D, Chetchotisakd P, Limmathurotsakul D, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PLoS Negl Trop Dis. 2009; 3:e407.10.1371/journal.pntd.0000407Open DOISearch in Google Scholar

14. Vasu C, Vadivelu J, Puthucheary SD. The humoral immune response in melioidosis patients during therapy. Infection. 2003; 31:24-30.10.1007/s15010-002-3020-2Open DOISearch in Google Scholar

15. White NJ. Melioidosis. Lancet. 2003; 361:1715-22.10.1016/S0140-6736(03)13374-0Open DOISearch in Google Scholar

16. Chaowagul W. Recent advances in the treatment of severe melioidosis. Acta Tropica. 2000; 74:133-37.10.1016/S0001-706X(99)00062-5Open DOISearch in Google Scholar

17. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson Andrew JH, et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprimsulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis. 2005; 41:1105-13.10.1086/444456Open DOISearch in Google Scholar

18. Jenny AWJ, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents. 2001; 17: 109-13.10.1016/S0924-8579(00)00334-4Open DOISearch in Google Scholar

19. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotics susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. JAC. 2004; 54: 1134-8.10.1093/jac/dkh47115509614Search in Google Scholar

20. Wuthiekanun V, Amornchai P, Saiprom N, Chantratita N, Chierakul W, Koh GCKW, et al. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in northeast Thailand. Antimicrob Agents Chemother. 2011; 11: 5388-91.10.1128/AAC.05517-11319505421876049Search in Google Scholar

21. Dance DA. Melioidosis. Curr Opin Infect Dis. 2002; 15:127-32.10.1097/00001432-200204000-00005Open DOISearch in Google Scholar

22. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989; 2: 697-701.10.1016/S0140-6736(89)90768-XOpen DOISearch in Google Scholar

23. Vorachit M, Lam K, Jayanetra P, Costerton JW. Electron microscopy study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo. J Trop Med Hyg. 1995; 98:379-91.Search in Google Scholar

24. Taweechaisupapong S, Kaewpa C, Arunyanart C, Kanla P, Homchumpa P. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog. 2005; 39:77-85.10.1016/j.micpath.2005.06.00116084684Open DOISearch in Google Scholar

25. Vorachit M, Lam K, Jayanetra P, Costerton JW. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic disc to ceftazidime and cotrimoxazole. Antimicrob Agents Chemother. 1993; 37: 2000-2.10.1128/AAC.37.9.20001881097694545Search in Google Scholar

26. Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010; 5:e9196.10.1371/journal.pone.0009196282054620169199Search in Google Scholar

27. Lee HS, Gu F, Ching SM, Lam Y, Chua KL. CdpA, a Burkholderia pseudomallei cyclic-di-GMP phosphodiesterase involved in autoaggregation, flagella synthesis, motility, biofilm formation, cell invasion and cytotoxicity. Infect immune. 2010; 78: 1832-40.10.1128/IAI.00446-09286350520194589Search in Google Scholar

28. Korbsrisate S, Vanaporn M, Kerdsuk P, Kespichayawattana W, Vattanaviboon P, Kiatpapan P, et al. The Burkholderia pseudomallei RpoE (AIgU) operon is involved in environmental stress tolerance and biofilm formation. FEMS Microbial Lett. 2005; 252:243-9.10.1016/j.femsle.2005.09.00216185818Search in Google Scholar

29. Puknum A, Tungpradabkul S, Taweechaisupapong S. Proteomic study of Burkholderia pseudomallei wild type and biofilm defective mutant in biofilm stimulating condition. Poster presentation on Commission on Higher Education Congress III University Staff Development. 2010.Search in Google Scholar

30. Niumsup P, Wuthiekanun V. Cloning of the class D - lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime susceptible and resistant strains. JAC. 2002; 50:445-55.10.1093/jac/dkf16512356787Search in Google Scholar

31. Livermore DM, Chau PY, Wong, AI, Leung YK. β-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. J Antimicrob Chemother. 1987; 20:313-21.10.1093/jac/20.3.3133500161Open DOISearch in Google Scholar

32. Cheung TK, Ho PL, Woo PC, Yuen KY, Chau PY. Cloning and expression of class A β-lactamase gene blaABPS in Burkholderia pseudomallei. Antimicrob Agents Chemother. 2002; 46:1132-5.10.1128/AAC.46.4.1132-1135.200212709111897607Search in Google Scholar

33. Chantratita N, Rholl DA, Sim B, Wuthiekanum V, Limmathurotsakul D, Amornchai P, et al. Antimicrobial resistance to ceftazidime involving loss of penicillinbinding protein 3 in Burkholderia pseudomallei. PNAS. 2012; 108:17165-70.10.1073/pnas.1111020108Search in Google Scholar

34. Davidson RN, Griffiths CJ, Wilkinson RJ. Neutrophil mediated innate immune resistance to mycobacteria. J Clin Invest. 2007; 117:1988-94.10.1172/JCI31097Open DOISearch in Google Scholar

35. Kanthawong S, Nazmi K, Wongratanacheewin S, Bolscher JGM, Wuthiekanun V, Taweechaisupapong S. In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides. Int J Antimicrob Agents. 2009; 34:309-14.10.1016/j.ijantimicag.2009.05.012Open DOISearch in Google Scholar

36. Panomket P, Wanrum S, Srivoramas T, Prongprom N. Bioactivity of plant extracts against Burkholderia pseudomallei. Asian Biomed. 2012; 6:619-23.Search in Google Scholar

37. Cheng AC, Stephens DP, Anstey NM, Currie BJ. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis. 2004; 38:32-7.10.1086/380456Open DOISearch in Google Scholar

38. Powell K, Ulett G, Hirst R, Norton R. G-CSF immunotherapy for treatment of acute disseminated murine melioidosis. FEMS Microbiol Lett. 2003; 224:315-8.10.1016/S0378-1097(03)00473-7Open DOISearch in Google Scholar

39. Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, et al. A randomized controlled trial of granulocyte colonystimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007; 45:308-14.10.1086/51926117599307Open DOISearch in Google Scholar

40. Panomket P, Chetchotisakd P, Sermswan RW, Pannengpetch P, Wongratanacheewin S. Use of low dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei. Ann Trop Med Parasitol. 2009; 103: 635-46. 10.1179/000349809X1250203577611719825285Open DOISearch in Google Scholar